Medicus Pharma Ltd
Biotechnology, 3494 Progress Dr, Bensalem, Pennsylvania, 19020, United States, 1-10 Employees
Phone Number: +12*********
Who is MEDICUS PHARMA LTD
Medicus Pharma Ltd. (TSXV:MDCX) is a clinical stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA a...
Read More
-
Headquarters: 3494 Progress Dr, Bensalem, Pennsylvania, 19020, United States
-
Date Founded: 2008
-
Employees: 1-10
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
-
CEO:
Raza Bokhari
Email
Phone
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 325414 |
Show More
Does something look wrong? Fix it. | View contact records from MEDICUS PHARMA LTD
Medicus Pharma Ltd Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Medicus Pharma Ltd
Answer: Medicus Pharma Ltd's headquarters are located at 3494 Progress Dr, Bensalem, Pennsylvania, 19020, United States
Answer: Medicus Pharma Ltd's phone number is +12*********
Answer: Medicus Pharma Ltd's official website is https://medicuspharma.com
Answer: Medicus Pharma Ltd's revenue is $10 Million to $25 Million
Answer: Medicus Pharma Ltd's SIC: 2836
Answer: Medicus Pharma Ltd's NAICS: 325414
Answer: Medicus Pharma Ltd has 1-10 employees
Answer: Medicus Pharma Ltd is in Biotechnology
Answer: Medicus Pharma Ltd contact info: Phone number: +12********* Website: https://medicuspharma.com
Answer: Medicus Pharma Ltd. (TSXV:MDCX) is a clinical stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials. Through our diverse experience and extensive industry network, we are building Medicus into a leading pharmaceutical holding company, committed to deliver better treatment outcomes and alleviate pain and suffering. Utilizing a thesis driven collaborative process, we identify, acquire and advance relatively de-risked clinical stage assets through clinical development and commercialization. We look into opportunities across all therapeutics areas where an unmet need exists for improved patient safety and efficacy. Medicus is actively exploring to expand its drug development pipeline through qualified and accretive acquisitions and partnerships. Our portfolio of companies include Skinject, Inc.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month